LFCRLIFECORE BIOMEDICAL, INC. \DE\vs its industry peers
A metric-by-metric comparison of LIFECORE BIOMEDICAL, INC. \DE\ against SIC 2834 — valuation, growth, profitability, quality and total return, with each figure's rank within the peer group. Every value is Go-computed from SEC filings and delayed prices; ranks are sorted positions within the group only — descriptive, not advice.
| 기업 | Market cap | P/E (TTM) | P/B | P/S | Revenue growth (YoY) | Earnings growth (YoY) | EBIT margin | ROE | ROIC | Piotroski F | 1y total return | Dividend yield |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| LFCR본 종목 | $168M#9 | — | — | 1.3x#2 | 0.5%#4 | -422.5%#11 | -13.4%#2 | — | -28.7%#2 | 3#1 | -42.0%#4 | — |
| TNXP | $195M#2 | — | 0.9x#3 | 14.9x#3 | 29.8%#2 | 4.6%#5 | -959.1%#3 | -55.8%#7 | -234.8%#5 | — | -58.9%#6 | — |
| ANTX | $195M#3 | — | 2.6x#9 | — | — | 31.5%#2 | — | -46.3%#5 | — | — | 298.5%#1 | — |
| KRRO | $189M#4 | — | 1.8x#7 | 29.6x#4 | 181.5%#1 | -40.3%#8 | -1906.4%#5 | -113.6%#10 | -155.2%#4 | — | -58.4%#5 | — |
| ORGO | $177M#5 | — | 1.2x#5 | 0.3x#1 | 17.0%#3 | 4011.1%#1 | 7.9%#1 | 25.0%#2 | 23.2%#1 | — | — | — |
| MNOV | $172M#6 | — | 4.6x#10 | 420.5x#6 | — | 8.6%#4 | -3242.5%#6 | 32.2%#1 | — | — | 185.7%#2 | — |
| NERV | $170M#7 | — | — | — | — | -20492.7%#12 | — | — | — | — | — | — |
| CNTN | $169M#8 | — | 0.4x#1 | — | — | -194.5%#10 | — | -7.9%#4 | — | — | — | — |
| RNA | $164M#10 | — | 0.8x#2 | — | — | — | — | 0.0%#3 | — | — | — | — |
| SPRB | $156M#11 | — | 1.9x#8 | — | -100.0%#5 | 26.5%#3 | — | -46.5%#6 | — | — | — | — |
| NRXP | $150M#12 | — | — | 122.6x#5 | — | -13.9%#7 | -1324.4%#4 | — | — | — | — | — |
| CRBP | $141M#13 | — | 1.4x#6 | — | -100.0%#5 | -95.3%#9 | — | -76.8%#9 | -93.1%#3 | — | — | — |
| IMUX | $139M#14 | 5.0x#1 | 1.1x#4 | — | — | 3.3%#6 | — | -76.2%#8 | — | — | 23.5%#3 | — |
| APMD | $1.2B#1 | — | — | — | — | — | — | — | — | — | — | — |
Peer set: US filers sharing this company's SEC industry classification (SIC 2834). SIC is coarse — conglomerates and multi-segment companies map imperfectly. Values from SEC filings + delayed prices; ranks are within-group positions only. Market cap, P/E, P/B, P/S, 1y total return and dividend yield are computed from each member's latest snapshot price when the table is built (see as-of; snapshot prices can lag) — not live. Some peers are still being computed, so this table covers part of the group and ranks are within the rows shown; it fills in shortly. 이 표는 생성 중 시간이 초과되어 그룹의 일부만 포함합니다. 순위는 표시된 행 내에서만 유효하며 곧 채워집니다. Table built 2026-09-17.
Source: SEC XBRL filings + delayed prices · ranks are within-group positions · For reference only · Not investment advice